Key Highlights

  • Algorae Pharmaceuticals Ltd (ASX: 1AI) shares closed flat during the 13 August 2026 session.
  • The stock traded within a narrow intraday range on notable volume.
  • Market capitalisation remained within the micro-cap range at close.
  • The one-year performance figure showed a marked increase compared to twelve months earlier.
  • The Health Care sector index posted a modest gain for the session.

Overview

Algorae Pharmaceuticals Ltd, trading under the ticker code 1AI on the Australian Securities Exchange (ASX), is categorised within the S&P/ASX 200 Health Care sector. This article presents a factual, educational summary of the company's share price activity for the session ending 13 August 2026, based only on figures recorded at market close on that date, and is not a recommendation regarding the stock.

Share Price Movement

Algorae Pharmaceuticals Ltd shares closed the session at $0.011, unchanged from the previous close, recording a percentage change of 0%. This means the stock's price neither rose nor fell over the course of the day. During the session, the share price moved between an intraday high of $0.011 and an intraday low of $0.01, a narrow range consistent with a session that finished flat.

As with other stocks priced at a fraction of a cent, this narrow range should be read in the context of the stock's low nominal price level, where small absolute movements can still register on a percentage basis.

Trading Volume and Market Capitalisation

A total of 443,902 shares were traded during the 13 August 2026 session, representing notable trading volume for Algorae Pharmaceuticals Ltd despite the price finishing unchanged.

At the closing price, the company's Market Capitalisation stood at approximately $22.3 million, placing it among the smaller companies by size within the listed Health Care sector.

One-Year Performance

Over the twelve months to 13 August 2026, Algorae Pharmaceuticals Ltd shares recorded a change of approximately 83.33%, indicating that the share price was higher than it stood a year earlier. This figure reflects the net outcome of price movements recorded across the full year rather than a description of a steady trend.

Health Care Sector Snapshot

The stock is part of the S&P/ASX 200 Health Care Index (ASX: XHJ), which closed the 13 August 2026 session at 29,014.4 points, up 50.0 points, or 0.17%, from the previous close of 28,964.4 points. During the session, the index moved between a day high of 29,130.7 points and a day low of 28,777.6 points. Over the past 52 weeks, the index has ranged between 21,947.2 points and 45,579.6 points, and it has recorded a decline of 35.29% on a one-year basis. This sector-level movement provides context for the individual performance of health care stocks listed on the exchange, though each company's price behaviour is also shaped by its own trading activity.

Conclusion

In summary, Algorae Pharmaceuticals Ltd (ASX: 1AI) shares closed the 13 August 2026 session unchanged, trading within a narrow range on notable volume. The company's smaller market capitalisation and its one-year performance figure, considered alongside the movement of the S&P/ASX 200 Health Care Index, provide a factual, point-in-time reference for readers. This article has been prepared for general educational purposes only and does not constitute financial advice.

Frequently Asked Questions (FAQs)